iStent infinite Trabecular Micro-Bypass System - Glaucoma micro-stent
Access comprehensive regulatory information for iStent infinite Trabecular Micro-Bypass System - Glaucoma micro-stent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by RQSolutions Medical Devices Distribution Support, manufactured by Glaukos Corporation in United States of America. The device registration started on March 28, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The iStent infinite Trabecular Micro-Bypass System Model iS3 is intended to reduce intraocular pressure in adult patients diagnosed with primary open-angle glaucoma (POAG) currently treated with ocular hypotensive medication. The device can be implanted with or without cataract surgery.